16
/
en
AIzaSyCYaC8UkdPkQKLFUmpasLV5eC3M802CrcA
Create
Public Timelines
Library
FAQ
Get Premium for free!
Download
Export
Duplicate
Embed
Edit
asdfg
Created by
Daniel Rossi
Comments
63 views
0
0
Updated
16 Oct 2017
Events
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD
